Research & Clinical Trials
Virginia Eye Institute is currently involved in multiple national eye studies & research trials. We assist in conducting studies used in the treatment of common eye diseases such as: cataracts, glaucoma, retinal disorders, cornea, dry eye, uveitis, and strabismus.
Our dedicated research team consists of trained & highly-qualified experts in eye care studies, including Certified Ophthalmic Technicians, Phlebotomists, Clinical Research Coordinators, Recruiters, and Research Assistants, and our research departments use state-of-the-art equipment and fully equipped eye exam rooms.
Upcoming Studies:
Geographic Atrophy (Retina)
Regeneron Pharmaceuticals: R3918-AMD-2326 & -2327
A Multicenter, Randomized, Double-Masked, Placebo-Controlled Phase 3 Study of the Efficacy, Safety, and Tolerability of Subcutaneously Administered Pozelimab in Combination with Cemdisiran or Cemdisiran Alone in Patients with Geographic Atrophy Secondary to Age-related Macular Degeneration (AMD)
Principal Investigator: Byron Ladd, MD
Thyroid Eye Disease/Proptosis
Hoffmann-La Roche Ltd: SatraGO-1 / GP44467; Satralizumab (RO5333787)
A Phase III, Randomized, Double-Masked, Placebo-Controlled, Multicenter Study to Evaluate the Efficacy, Safety, Pharmacokinetics, and Pharmacodynamics of Satralizumab in Participants with Moderate-to-Severe Thyroid Eye Disease
Principal Investigator: William Bearden, MD
Sub Investigator: Irfan Khan, MD
Location: 6946 Forest Avenue, Richmond, VA 23230
Recent Completed Studies:
Shingles of The Eye (2018-2024)
Zoster Eye Disease Study (ZEDS)
Long-term Suppressive Valacyclovir Treatment for Herpes Zoster Ophthalmicus
Principal Investigator: Christopher Estopinal, MD
Sub Investigator : Donna Brown, MD
Dry Eye (2021-2024)
A Phase 3 Study Evaluating the Safety and Efficacy of AR-15512, a Cold Thermoreceptor Modulator, for the Treatment of Dry Eye Disease (COMET-3)
Principal Investigators:
Phillip Cofoid, MD (2023-2024)
Marc Malouf, MD (2021-2023)
Sub-Investigators:
Christopher Estopinal, MD
Esther Han, OD
Matlock Wyman, OD
Cameron Lindsey, OD
Shannon Robinson, OD
Seasonal Allergic Conjunctivitis (2023)
Evaluation of the Combination Drug Product Brimonidine Tartrate 0.025%/Ketotifen Fumarate 0.035% Ophthalmic Solution Compared to Its Components and Vehicle in an Allergen BioCube® in Subjects With Seasonal Allergic Conjunctivitis
Principal Investigator: Irfan Khan MD
Sub Investigators:
Esther Han, OD
Matlock Wyman, OD
Shannon Robinson, OD
Retina Home Device (2021-2022)
Home OCT Fluid Visualization Agreement Study (C2021.001)
Home OCT Fluid Visualization Agreement Study at Multiple Retinal Clinics With Placement of One Home OCT Device in the Home of Each NV-AMD Subject in the US for 5 Weeks
Principal Investigator:
Byron Ladd, MD
Sub Investigators:
David Jacobs, MD
Ryan Deasy, MD
Past Studies
- 2017-Omaspect
- 2016-2017 Ophthotech
- 2016-DRCR Study
- 2016-Allergan
- 2016-Tyrogenex
- 2016-Lampalizumab
- 2016- Alcon (Hawk Studies)
- 2007-2013 RIDE Study
- 2004-2009 SCORE Study
- 2005-2008 Horizon Study
- 2003-2007 DRCR Study
- 2003-2006 Genentech Marina Study
- 2001-2006 Eli Lily Diabetic Study
- 2001-2006 Diabetic FL005 and FL007 Study
We are always welcome to hear from patients or individuals in our communities who are interested in participating in one of our research studies. If you are interested in participating in one of our studies, please call (804) 287-4250 or fill out the form below to sign up for our Research Study Newsletter:
